These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 26242980)
1. Fractional flow reserve, maximum hyperemia, adenosine, and regadenoson. Pijls NH; van Nunen LX Cardiovasc Revasc Med; 2015; 16(5):263-5. PubMed ID: 26242980 [No Abstract] [Full Text] [Related]
2. Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory. Stolker JM; Lim MJ; Shavelle DM; Morris DL; Angiolillo DJ; Guzman LA; Kennedy KF; Weber E; Zareh M; Neumayr RH; Zenni MM Cardiovasc Revasc Med; 2015; 16(5):266-71. PubMed ID: 26242981 [TBL] [Abstract][Full Text] [Related]
3. The crux of maximum hyperemia: the last remaining barrier for routine use of fractional flow reserve. Pijls NH; Tonino PA JACC Cardiovasc Interv; 2011 Oct; 4(10):1093-5. PubMed ID: 22017934 [No Abstract] [Full Text] [Related]
4. Use of regadenoson for measurement of fractional flow reserve. Prasad A; Zareh M; Doherty R; Gopal A; Vora H; Somma K; Mehra A; Clavijo LC; Matthews RV; Shavelle DM Catheter Cardiovasc Interv; 2014 Feb; 83(3):369-74. PubMed ID: 23765847 [TBL] [Abstract][Full Text] [Related]
5. Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement. van Nunen LX; Lenders GD; Schampaert S; van 't Veer M; Wijnbergen I; Brueren GR; Tonino PA; Pijls NH EuroIntervention; 2015 Dec; 11(8):905-13. PubMed ID: 25136887 [TBL] [Abstract][Full Text] [Related]
6. Regadenoson for FFR: time to say good-bye to adenosine? Hakeem A; Uretsky B Catheter Cardiovasc Interv; 2014 Feb; 83(3):375-6. PubMed ID: 24497454 [No Abstract] [Full Text] [Related]
7. Variability of fractional flow reserve according to the methods of hyperemia induction. Lim WH; Koo BK; Nam CW; Doh JH; Park JJ; Yang HM; Park KW; Kim HS; Takashima H; Waseda K; Amano T; Kato D; Kurita A; Oi M; Toyofuku M; van Nunen L; Pijls NH Catheter Cardiovasc Interv; 2015 May; 85(6):970-6. PubMed ID: 25413590 [TBL] [Abstract][Full Text] [Related]
9. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309 [TBL] [Abstract][Full Text] [Related]
10. Fractional Flow Reserve in the Transradial Era: Will Hand Vein Adenosine Infusion Suffice?: A Comparative Study of the Extent, Rapidity, and Stability of Hyperemia From Hand and Femoral Venous Routes of Adenosine Administration. Scott P; Sirker A; Dworakowski R; Paul G; Candilio L; Jahagirdar N; Melikian N; Byrne J JACC Cardiovasc Interv; 2015 Apr; 8(4):527-35. PubMed ID: 25819188 [TBL] [Abstract][Full Text] [Related]
11. [A novel way to induce coronary hyperaemia]. Tkaczewski K; Dziuk M; Kocki J; Pińkowski R Postepy Hig Med Dosw (Online); 2013 Sep; 67():933-7. PubMed ID: 24088536 [TBL] [Abstract][Full Text] [Related]
12. Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve. Arumugham P; Figueredo VM; Patel PB; Morris DL EuroIntervention; 2013 Feb; 8(10):1166-71. PubMed ID: 23164748 [TBL] [Abstract][Full Text] [Related]
13. Intracoronary adenosine administration in the right coronary artery: a word of caution. Brilakis ES; Banerjee S JACC Cardiovasc Interv; 2012 Feb; 5(2):245; author reply 245. PubMed ID: 22361612 [No Abstract] [Full Text] [Related]
14. Feasibility, safety and effectiveness in measuring microvascular resistance with regadenoson. Lachmann V; Heimann M; Jung C; Zeus T; Verde PE; Kelm M; Bönner F Clin Hemorheol Microcirc; 2019; 71(3):299-310. PubMed ID: 30103305 [TBL] [Abstract][Full Text] [Related]
15. Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. De Luca G; Venegoni L; Iorio S; Giuliani L; Marino P JACC Cardiovasc Interv; 2011 Oct; 4(10):1079-84. PubMed ID: 22017932 [TBL] [Abstract][Full Text] [Related]
16. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics. Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310 [TBL] [Abstract][Full Text] [Related]
17. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans. Lieu HD; Shryock JC; von Mering GO; Gordi T; Blackburn B; Olmsted AW; Belardinelli L; Kerensky RA J Nucl Cardiol; 2007 Jul; 14(4):514-20. PubMed ID: 17679059 [TBL] [Abstract][Full Text] [Related]
18. On the search for an "easy" FFR: Submaximal hyperemia and NTG-induced translesional pressure drop (Pd/Pa-NTG). Kern MJ; Seto AH Catheter Cardiovasc Interv; 2016 Feb; 87(2):270-2. PubMed ID: 26876511 [No Abstract] [Full Text] [Related]
19. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications. Palani G; Ananthasubramaniam K Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345 [TBL] [Abstract][Full Text] [Related]
20. Is Caffeine Abstention Necessary Before Adenosine-Induced Fractional Flow Reserve Measurement? Matsumoto H; Ushimaru S; Matsuda T; Shimada T; Mikuri M; Takahashi H; Takahashi N; Kawada T; Yamazaki T J Am Coll Cardiol; 2015 Oct; 66(17):1943-5. PubMed ID: 26493668 [No Abstract] [Full Text] [Related] [Next] [New Search]